Skip to main content

Eli Lilly confirms probe by New York's Attorney General over insulin prices

Eli Lily, the maker of blockbuster diabetes treatment Humalog, has been under scrutiny from U.S. lawmakers and the White House over the high cost of its life-saving medication.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.